|
|
Volumn 11, Issue 11, 2000, Pages 1275-1284
|
|
Angiogenic mechanisms of endothelialization of cardiovascular implants: A review of recent investigative strategies
|
|
Author keywords
Angiogenesis; Cardiovascular implants; Growth factors
|
|
Indexed keywords
ANGIOGENIC FACTOR;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BIOMATERIAL;
FIBROBLAST GROWTH FACTOR 1;
FIBROBLAST GROWTH FACTOR 2;
HEPARIN;
MITOGENIC AGENT;
PEPTIDE;
PLEIOTROPHIN;
VASCULOTROPIN;
ANGIOGENESIS;
ANIMAL TISSUE;
ARTERY;
ARTERY INTIMA PROLIFERATION;
ARTERY WALL;
ARTICLE;
BABOON;
BLOOD;
BLOOD VESSEL DIAMETER;
BLOOD VESSEL GRAFT;
CARDIOVASCULAR SYSTEM;
CELL PROLIFERATION;
CELL SPECIFICITY;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DEVICE;
DOG;
DRUG DELIVERY SYSTEM;
ENDOTHELIUM;
ENDOTHELIUM CELL;
IMPLANT;
IN VITRO STUDY;
ISCHEMIA;
MOLECULAR INTERACTION;
MUTAGENESIS;
MUTANT;
NONHUMAN;
PRIORITY JOURNAL;
PROSTHESIS;
SMOOTH MUSCLE FIBER;
STIMULATION;
SURFACE PROPERTY;
THROMBOGENICITY;
THROMBOSIS;
TISSUE;
ANIMALS;
BLOOD VESSEL PROSTHESIS;
CORONARY CIRCULATION;
ENDOTHELIUM, VASCULAR;
GROWTH SUBSTANCES;
HUMANS;
NEOVASCULARIZATION, PHYSIOLOGIC;
|
|
EID: 0034464696
PISSN: 09205063
EISSN: None
Source Type: Journal
DOI: 10.1163/156856200744200 Document Type: Article |
|
Times cited : (51)
|
|
References (37)
|
